This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Five-Year Outcomes With Conformable GORE® TAG® Endoprosthesis Used in Traumatic Aortic Transections

Monday, July 12, 2021

Submitted by


Source Name: The Annals of Thoracic Surgery


Mark A. Farber, M.D., Kambhampaty V. Krishnasastry, M.D., Nimesh Desai, M.D., Ph.D., Benjamin W. Starnes, M.D., Jon S. Matsumura, M.D., Beth C. Tohill, M.S.P.H., Ph.D., on behalf of the TAG 08-02 clinical trial investigators

In this article, Dr. Farber et al. describe the acceptable five year outcomes of using the Conformable GORE® TAG® thoracic endoprosthesis (CTAG) device (W.L. Gore and Associates, Flagstaff, AZ) for thoracic endovascular repair (TEVAR) of blunt aortic injuries in a prospective, single-arm study among 111 patients. 


Add comment

Log in or register to post comments